Sichuan Kelun Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000PW7
CNY
32.97
-1.4 (-4.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sichuan Kelun Pharmaceutical Co., Ltd.

Why is Sichuan Kelun Pharmaceutical Co., Ltd. ?

1
With a fall in Net Sales of -15.48%, the company declared Very Negative results in Sep 25
  • The company has declared negative results for the last 2 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at CNY 3,073.46 MM
  • ROCE(HY) Lowest at 7.2%
  • INTEREST(Q) At CNY 29.99 MM has Grown at 10.11%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sichuan Kelun Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sichuan Kelun Pharmaceutical Co., Ltd.
4.4%
0.07
39.94%
China Shanghai Composite
13.33%
0.90
14.74%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.29%
EBIT Growth (5y)
11.33%
EBIT to Interest (avg)
9.46
Debt to EBITDA (avg)
1.25
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.77
Tax Ratio
22.04%
Dividend Payout Ratio
41.02%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.99%
ROE (avg)
10.61%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
2.49
EV to EBIT
22.46
EV to EBITDA
14.42
EV to Capital Employed
2.75
EV to Sales
2.92
PEG Ratio
NA
Dividend Yield
1.91%
ROCE (Latest)
12.26%
ROE (Latest)
9.45%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
CASH AND EQV(HY)

Highest at CNY 15,924.22 MM

DEBT-EQUITY RATIO (HY)

Lowest at -14.86 %

-39What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 3,073.46 MM

ROCE(HY)

Lowest at 7.2%

INTEREST(Q)

At CNY 29.99 MM has Grown at 10.11%

INTEREST COVERAGE RATIO(Q)

Lowest at 514.53

RAW MATERIAL COST(Y)

Grown by 9.04% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.92 times

NET SALES(Q)

Lowest at CNY 4,193.4 MM

OPERATING PROFIT(Q)

Lowest at CNY 154.29 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 3.68 %

PRE-TAX PROFIT(Q)

Lowest at CNY 189.66 MM

NET PROFIT(Q)

Lowest at CNY 196.98 MM

EPS(Q)

Lowest at CNY 0.13

Here's what is working for Sichuan Kelun Pharmaceutical Co., Ltd.

Cash and Eqv
Highest at CNY 15,924.22 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -14.86 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Sichuan Kelun Pharmaceutical Co., Ltd.

Pre-Tax Profit
At CNY 189.66 MM has Fallen at -75.3%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 196.98 MM has Fallen at -70.34%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow
Lowest at CNY 3,073.46 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest
At CNY 29.99 MM has Grown at 10.11%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio
Lowest at 514.53
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Sales
Lowest at CNY 4,193.4 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Net Sales
Fallen at -15.48%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit
Lowest at CNY 154.29 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 3.68 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at CNY 189.66 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit
Lowest at CNY 196.98 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS
Lowest at CNY 0.13
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio
Lowest at 2.92 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 9.04% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income
Highest at CNY 0.33 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income